Home › Myalgic Encephalomyelitis/Chronic Fatigue Syndrome › NCT07551999
A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS
RecruitingObservational study
Use Of A Remote Voice Analysis Tool For Diagnosing And Monitoring Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) verified by an ME/CFS specialist. * Ability to complete study questionnaires and provide voice samples using a smartphone application. * Consistent access to a smartphone or tablet with iOS or Android operating systems, or a laptop. Exclusion Criteria: * No diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); "Chronic Fatigue Syndrome" not verified by an ME/CFS specialist. * Lack of consistent access to a smartphone or tablet with iOS or Android operating systems, or laptop. * Known dementia or other neurodegenerative disorder prominently affecting cognition or speech patterns. outside of ME/CFS * Known history of voice disorder either primary or secondary to neuromuscular or other pathology outside of ME/CFS * Known clinically significant heart failure or greater than moderate pulmonary hypertension.
About the study
The purpose of this research is to evaluate the use of a voice-based tool in the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
What is being tested
- Voice Recording (other)
Sponsor: Mayo Clinic · Participants: 40 · Started: May 26, 2026
Contact the study team
- Katie Cruz · Phone: 507-284-5404
Official record on ClinicalTrials.gov — NCT07551999
Locations in the U.S.
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.